ストックスクリーナーアプリを入手
44.18
4.05%
-1.822
前日終値:
$46.00
開ける：
$47
24時間の取引高:
9,257
Relative Volume:
0.29
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+20.67%
1か月 パフォーマンス:
+8.95%
6か月 パフォーマンス:
-46.00%
1年 パフォーマンス:
+81.57%
1日の値動き範囲:
$44.05
$47.00
1週間の範囲:
$36.31
$47.00
52週間の値動き範囲:
$22.85
$94.00
Tradr 2 X Long Innovation Etf Stock (TARK) Company Profile
Compare TARK vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TARK
Tradr 2 X Long Innovation Etf
|
44.18 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
344.69 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
698.92 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
702.15 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
278.52 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
636.76 | 124.43B | 0 | 0 | 0 | 0.00 |
Tradr 2 X Long Innovation Etf (TARK) 最新ニュース
Sana VitaHoney Redefines Everyday Wellness with Portable Honey Spoon Innovation - Barchart.com
HPV+ Recurrent/Metastatic Head and Neck Cancer Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
KingKonree KKR Showcases Solid Surface Innovation at kbb Birmingham 2026, Expanding UK Market Presence - Barchart.com
Diabetic Nephropathy Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Helixmith, Lexicon Pharma, Glenmark Pharma, Regenacy Pharma, Praetego - Barchart.com
3 ETFs to Buy Now If You Want to Invest Directly in OpenAI - Barchart.com
BK Virus Infection Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Cathie Wood Is Now Letting You Invest Directly in OpenAI Through Her Flagship ARKK ETF - Barchart.com
Tradr 2X Long IBM Daily ETF (IBX) Interactive Stock Chart - Yahoo! Finance Canada
US Stock ETF Tracker | Cryptocurrency-related stocks weakened collectively, with 2x Inverse CRCL surging 40% and 2x Inverse COIN rising over 20%; large orders boosted share prices, driving 2x Long AAOI up more than 35%; venture capital fund VCX conti - 富途牛牛
U.S. Equity ETF Tracker | Trump issues easing signal; 2x Inverse Bloomberg Crude Oil rises over 10%; Unicorn Fund VCX surges fivefold in three days, adding another 63%; Quantum computing concept strengthens, with 2x Long RGTI rising over 13%. - 富途牛牛
Tradr Set to Launch Leveraged ETFs on AMZN, AAOI, HL and IBM - Stocktwits
Tradr ETFs Reaches $3 Billion AUM Milestone in Under Two Years - MSN
Anaergia Inc. Schedules Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call - Stocktwits
Tradr 2X Long Innovation ETF (NASDAQ:TARK) Short Interest Down 13.7% in February - Defense World
TEMT News Today | Why did Tradr 2X Long TEM Daily ETF go dropping today? - MarketBeat
Bloom Energy, NuScale Power Buzz Drives ETF Action — Tradr Bets Double-Down Bear Plays - MSN
EMA Aesthetics Announces Strategic Investment in MonoTx and Secures Board Representation, Advancing Regenerative Aesthetics Innovation - Barchart.com
TARK News Today: Stay Updated with the Latest Tradr 2X Long Innovation ETF (TARK) News in Real Time - Meyka
5 Best Artificial Intelligence (AI) ETFs to Buy in 2026 - The Motley Fool
Mixed options sentiment in Tradr 2X Long CLSK Daily ETF with shares down 1.09% - TipRanks
GraniteShares Launches ISRG and NBIS Leveraged Single-Stock ETFs: ISUL & NBIL - Stocktwits
Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Dan Herbatschek New York: Applied Mathematician and Technology Executive Continues to Shape Data-Driven Innovation - Barchart.com
Tradr 2X Long Innovation 100 Monthly ETF (MQQQ) Fundamental Analysis - Meyka
Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Cathie Wood Bought the Dip in Robinhood Stock. Should You Buy HOOD in February 2026 Too? - Barchart.com
Franklin Templeton Canada Announces ETF Cash Distributions - Barchart.com
Cathie Wood Is Selling Unity Software Stock Amid an ‘Apocalypse.’ Should You? - Barchart.com
Tradr Debuts Leveraged ETFs on Centrus Energy, CleanSpark and Coherent - IT-TIMES
Coherent Corp. to Host a Technology Innovation Briefing on March 17, 2026 - Barchart.com
Tofu Market Size to Reach USD 3.77 Billion by 2031 as Flexitarian Diets and Product Innovation Accelerate Growth - Barchart.com
Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% - Barchart.com
Tradr 2X Long Innovation ETF (TARK) ETF HoldersInstitutional Ownership - GuruFocus
Tradr 2X Long CLSK Daily ETF call volume above normal and directionally bullish - Yahoo Finance
As Cathie Wood Gobbles Up the Dip in Broadcom Stock, Should You Add AVGO Too? - Barchart.com
Innovative Industrial Properties Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Barchart.com
Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte, Novartis - Barchart.com
Fresh, Bold, Protein-Packed: Wendy's Introduces Two Savory Menu Innovations - Barchart.com
Breast Cancer Clinical Trial Pipeline Expands as 250+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
As Crypto Prices Plunge, Cathie Wood Is Selling This 1 Bitcoin Stock - Barchart.com
Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com
Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Resideo Wins Two 2026 IoT Breakthrough Awards for Smart Home Innovation - Barchart.com
Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson, Janssen Pharma, F. Hoffmann-La Roche., Merck - Barchart.com
Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com
Tradull’s Innovative Model: Enabling Individual Participation in Global Commodities Trade - Barchart.com
VenHub Wins RTIH Award for Most Innovative Retailer - Barchart.com
CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure - Barchart.com
Cathie Wood Keeps Buying Joby Aviation Stock. Should You? - Barchart.com
Lindemann & Partner Launches Innovative Platform for Certified Contract Terminations in Germany - Barchart.com
Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation - Barchart.com
Tradr 2 X Long Innovation Etf (TARK) 財務データ
Tradr 2 X Long Innovation Etf (TARK) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.12%
0.33%
大文字化:
|
ボリューム (24 時間):